Cell News and Research

RSS

Researchers identify molecular target to improve pancreatic cancer treatment

Pancreatic cancer is one of the most aggressive and difficult-to-treat cancers. One reason for its resistance to therapy is the dense tissue surrounding the tumor, which acts as a protective barrier and suppresses the immune response.

23 Oct 2026

Maternal stress alters placental pathways affecting fetal brain development

About one in five U.S. women experience maternal mental health conditions, and chronic stress during pregnancy can contribute to risk for both maternal and child health challenges.

23 Oct 2026

Study identifies potential new ways to treat the most common type of bowel cancer

Major new research published today identifies potential new ways to treat the most common type of bowel cancer in Ireland.

23 Oct 2026

BioUK Awards 2026 celebrate outstanding achievement and breakthrough innovations from across the life sciences

BioUK, the not-for-profit membership organization focused on catalyzing success in UK life sciences, today announced the winners of the 18th annual BioUK Awards following a ceremony hosted at the Royal Lancaster Hotel, London.

From BioUK 23 Oct 2026

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Discover how omics is transforming life sciences with expert insights from Dr. Shi-Qi An on multiomics, single-cell research and drug discovery.

23 Oct 2026

Researchers harness cancer cells' carbon monoxide to produce anticancer drug

What if we could use a cancer's own byproduct to make drugs that destroy tumor cells from the inside? That is exactly what Katsunori Tanaka and his team have done at the RIKEN Pioneering Research Institute (PRI) in Japan.

23 Oct 2026

Dual-targeted therapy shows promise against metastatic triple-negative breast cancer

A new preclinical study suggests that attacking triple-negative breast cancer (TNBC) in two ways at once can kill cancer cells, slow tumor growth and limit the cancer's spread. Researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) developed the approach.

23 Oct 2026

Postpartum recovery may influence long-term maternal aging and health

Jesse Poganik, PhD, of the Division of Genetics within the Department of Medicine at Mass General Brigham, is the senior author of a paper published in Trends in Endocrinology & Metabolism, "The Postpartum Recovery Window as a Determinant of Maternal Aging." Stephen Albright, formerly of Mass General Brigham, is the lead author.

23 Oct 2026

Psilocybin reshapes brain connections through distinct cellular pathways

A new study led by researchers at the University of California, Santa Cruz, reveals how psilocybin, the psychoactive compound in "magic mushrooms," reshapes neural connections in the brain.

22 Oct 2026

Scientists studied one million immune cells and found clues to future disease risk

Researchers developed a single-cell atlas of one million human neutrophils, identifying distinct immune cell populations and gene-expression patterns across tissues, infections, cancer, and other health conditions. Certain neutrophil signatures were associated with metabolic dysfunction, cancer outcomes, and mortality, while higher routine neutrophil counts, even within the normal range, were linked to an increased risk of chronic disease.

22 Oct 2026

Unstable immune cells linked to severe cancer immunotherapy side effects

Scientists at the University of Pittsburgh uncovered the unstable immune cells that can cause up to 40% of immunotherapy patients to experience serious side effects and showed that diet and microbiome composition influence the side effect's severity.

22 Oct 2026

Transplanted placental cells successfully detected in mouse pancreas after birth

The pancreas is a complex organ comprising multiple cell types that regulate blood glucose levels through hormones, such as insulin, and support digestion by producing digestive enzymes.

22 Oct 2026

Short gaps between pregnancies may accelerate biological aging in mothers

The study of biological aging, how our cells, tissues, and organs change over time, independent of how many years have passed, is a growing area of research that aims to help scientists understand the root causes of chronic illnesses and find ways to enhance longevity.

22 Oct 2026

Obesity impairs key immune cells but bariatric surgery reverses damage

New Maynooth University (MU) research led by the Department of Biology's Dr Ciara Flynn, working within the research group of Prof Andrew Hogan at the Kathleen Lonsdale Institute for Human Health Research has found that obesity can impair key immune cells that help protect the body against infection and cancer.

22 Oct 2026

Zylidac Bio and Prolific Machines partner to scale Prolific’s next-generation biologics manufacturing platform to GMP production

Zylidac Bio, a fully integrated biologics CDMO within the Zydus Lifesciences Limited (Zydus) group, and Prolific Machines, a biotechnology company advancing biologics development and manufacturing through integrated optogenetics-enabled solutions delivering breakthrough yields, superior on-target quality, and precise process control, today announced a partnership to scale Prolific's platform from early development through GMP production.

From Zylidac Bio LLC 22 Oct 2026

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Discover expert insights into single-cell proteomics, revealing protein diversity and non-canonical biology with advanced mass spectrometry

From Bruker Daltonics 22 Oct 2026

BGI Genomics smarter stool testing detects colorectal cancer across Latin America

BGI Genomics' COLOTECT® addresses colorectal cancer in LATAM through innovative non-invasive screening, enhancing early detection and treatment efficiency.

From BGI Genomics 22 Oct 2026

INmune Bio establishes global commercialization framework for Ebstrocel™ through strategic agreement with Uniphar

INmune Bio Inc. (the “Company”), a late-stage biotechnology company focused on inflammation and immunology, today announced that it has entered into a Master Services Agreement with Uniphar Durbin Ireland Limited (“Uniphar”) establishing a scalable framework to support international access, distribution and commercialization of Ebstrocel™, the Company’s allogeneic stromal cell therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB).

From INmune Bio 22 Oct 2026

Stem cell therapies may need new protein quality control standards

Current Good Manufacturing Practice (GMP) standards for cell therapies assess identity, viability, sterility, and genetic stability. For extracellular vesicle (EV) products, Minimal Information for Studies of Extracellular Vesicles (MISEV2023) guidance adds particle size, concentration, markers, morphology, contaminants, endotoxin, and assays.

22 Oct 2026

Southampton scientists explore immune cell reprogramming to fight common viruses

Scientists have started work on a new way to fight cold and flu viruses by reprogramming the cells in our immune system to respond faster to infections.

21 Oct 2026

Previous
1
...
6
7
8
9
10
11
12
...
4186
Next

Cell News and Research

Researchers identify molecular target to improve pancreatic cancer treatment

Maternal stress alters placental pathways affecting fetal brain development

Study identifies potential new ways to treat the most common type of bowel cancer

BioUK Awards 2026 celebrate outstanding achievement and breakthrough innovations from across the life sciences

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Researchers harness cancer cells' carbon monoxide to produce anticancer drug

Dual-targeted therapy shows promise against metastatic triple-negative breast cancer

Postpartum recovery may influence long-term maternal aging and health

Psilocybin reshapes brain connections through distinct cellular pathways

Scientists studied one million immune cells and found clues to future disease risk

Unstable immune cells linked to severe cancer immunotherapy side effects

Transplanted placental cells successfully detected in mouse pancreas after birth

Short gaps between pregnancies may accelerate biological aging in mothers

Obesity impairs key immune cells but bariatric surgery reverses damage

Zylidac Bio and Prolific Machines partner to scale Prolific’s next-generation biologics manufacturing platform to GMP production

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

BGI Genomics smarter stool testing detects colorectal cancer across Latin America

INmune Bio establishes global commercialization framework for Ebstrocel™ through strategic agreement with Uniphar

Stem cell therapies may need new protein quality control standards

Southampton scientists explore immune cell reprogramming to fight common viruses

Improve fermentation and cell culture performance with real-time gas analysis eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery